5th Nov 2024

Department for Business and Trade spotlight on UK genomics

genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, is pleased to anno...

4th Nov 2024

Scottish Health Technology Group publishes two Technology Assessments including genedrive’s CYP2C19 ID and MT-RNR1 and kits

genedrive plc (AIM: GDR), the point-of-care pharmacogenetic testing company, announces that in ...

12th Aug 2024

First UK commercial sales of the Genedrive® CYP2C19 ID Kit

genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, is pleased to anno...